Absci (ABSI) Depreciation and Depletion (2020 - 2024)
Absci (ABSI) reported Depreciation and Depletion of $2.4 million for Q4 2024, down 7.69% on a YoY basis from $2.6 million in Q1 2024, and down 4.0% sequentially from $2.5 million in Q3 2024.
Absci (ABSI) Depreciation and Depletion (2020 - 2024) Analysis & Trends
Absci (ABSI) has 5 years of Depreciation and Depletion data on file, last reported at $2.4 million in Q4 2024.
- For the quarter ending Q4 2024, Depreciation and Depletion fell 7.69% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2024 stood at $10.2 million (down 4.67% YoY), and the FY2025 full-year result was $8.4 million, down 16.0% from the prior year.
- Depreciation and Depletion eased to $2.4 million in Q4 2024, from $2.5 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $2.8 million in Q4 2022 to a low of $300000.0 in Q2 2020.
- A 5-year average of $1.8 million and a median of $2.3 million in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 533.33% in 2021 and retreated 7.69% in 2024, its largest moves.
- Tracing ABSI's Depreciation and Depletion over 5 years: stood at $300000.0 in 2020, then jumped by 533.33% to $1.9 million in 2021, then jumped by 47.37% to $2.8 million in 2022, then dropped by 7.14% to $2.6 million in 2023, then fell by 7.69% to $2.4 million in 2024.
- Business Quant data shows ABSI's Depreciation and Depletion at $2.4 million in Q4 2024, $2.5 million in Q3 2024, and $2.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.40 Mn |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.70 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Sep 30, 2022 | 2.60 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Mar 31, 2022 | 2.10 Mn |